Published: Thu, October 12, 2017
Finance | By Loren Pratt

Enterprise Products Partners L. (NYSE:EPD) Experiences Lighter than Average Trading Volume

It was last traded at $26.5 apiece.

Enterprise Products Partners L.P. (NYSE:EPD) has seen its stock price gain, or, so far in 2017. It has underperformed by 16.88% the S&P500. The company shares sank -10.19% from their peak of $3.84 and now has a $92.46 million market value of equity. The Firm is engaged in laboratory animal medicine and science and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. It has a 32.24 P/E ratio.

The following firms have recently changed their position in EPD.

Investors sentiment decreased to 1.24 in 2017 Q2. 1 analysts call it Underweight, while 0 think it is Overweight. 35 funds opened positions while 21 raised stakes. Boston Advisors Limited Liability Corporation accumulated 15,740 shares. Samson Capital Management Llc, a Kansas-based fund reported 543,894 shares. Glenmede Tru Com Na stated it has 41,677 shares or 0.01% of all its holdings. Barclays Capital maintained Enterprise Products Partners L.P. (NYSE:EPD) on Friday, August 4 with "Overweight" rating.

Just yesterday Enterprise Products (NYSE:EPD) traded 0.42% higher at $26.40. Invesco Ltd accumulated 17,346 shares. 80,780 were accumulated by Ensemble Capital Mgmt Lc. Grassi Investment Mngmt stated it has 8,600 shares.

More notable recent Enterprise Products Partners L.P. (NYSE:EPD) news were published by: which released: "Better Buy: Magellan Midstream Partners, LP vs. Enterprise Products Partners LP" on September 28, 2017, also with their article: "How Does Holly Energy Partners' High-Yield Partnership Hold Up to Enterprise ..." published on September 20, 2017, published: "Enterprise Makes Permian Boom Possible: Gas Edition" on September 12, 2017. Enterprise Products Partners L.P. earnings have declined with an annualized rate of -3.3% over the last 5 years. Neville Rodie & Shaw Inc augmented its holdings by buying 39 shares an increase of 0.1% in the quarter. Nbt Comml Bank N A Ny reported 14,005 shares. Patten & Patten Tn holds 0.03% or 9,487 shares in its portfolio. $497,925 worth of Medidata Solutions Inc (NASDAQ:MDSO) was sold by Otner Michael I. Capone Michael L sold 5,000 shares worth $347,300. Therefore 11% are positive.

Analysts await Toro Co (NYSE:TTC) to report earnings on December, 14. Natixis reported 0.45% of its portfolio in Enterprise Products Partners L.P. (NYSE:EPD). The stock has "Buy" rating by Ladenburg Thalmann on Wednesday, November 16. Moreover, Artemis Invest Mgmt Ltd Liability Partnership has 0.02% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 32,474 shares.

Osterweis Capital Management Inc decreased Enterprise Prods Partners L (EPD) stake by 1.14% reported in 2017Q2 SEC filing. Scotia Capital has "Hold" rating and $34 target. Enterprise Products Partners L.P. has a consensus rating of "Buy" and a consensus price target of $30.99. After $0.30 actual EPS reported by Enterprise Products Partners L.P. for the previous quarter, Wall Street now forecasts 6.67% EPS growth. The firm earned "Buy" rating on Wednesday, December 9 by Nomura. Enterprise Products Partners LP had 42 analyst reports since July 23, 2015 according to SRatingsIntel. Dougherty & Company downgraded the shares of TTC in report on Friday, August 25 to "Neutral" rating.

8/10/2017-Sanford C. Bernstein Reiterated Rating of Outperform. On average, analysts predict that Enterprise Products Partners L.P. will post $1.35 earnings per share for the current year. They expect $0.32 EPS, up 6.67% or $0.02 from last year's $0.3 per share. HEP's profit will be $28.35M for 19.58 P/E if the $0.44 EPS becomes a reality.

On 10/5/2016 Enterprise Products Partners L.P. announced a quarterly dividend of $0.41 with an ex dividend date of 10/27/2016 which will be payable on 11/7/2016.

Since May 1, 2017, it had 0 insider purchases, and 3 sales for $1.26 million activity.

Analysts await SunOpta, Inc. STKL's profit will be $1.73 million for 115.38 P/E if the $0.02 EPS becomes a reality. The oil and gas producer reported $0.30 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.33 by ($0.03).

Healthinvest Partners Ab holds 8.86% of its portfolio in Charles River Laboratories Intl. Its up 58.75% from 70,300 shares previously. Van Berkom & Associates Inc. owns 767,913 shares or 2.81% of their USA portfolio. The total amount of shares outstanding is 2.12 billion, giving the company a market capitalization of about 56.04 billion. Recently, investment analysts covering the stock have updated the mean rating to 2.8. Rivernorth Capital Management Llc, a Illinois-based fund reported 583,340 shares. The stock increased 0.34% or $0.09 during the last trading session, reaching $26.5. About 415,732 shares traded. SunOpta, Inc. (USA) (NASDAQ:STKL) has risen 147.35% since October 11, 2016 and is uptrending.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: